Dana-Farber Cancer Institute HandbookEdited by
- Arthur Skarin, MD, FACP, FCCP, Associate Professor of Medicine, Harvard Medical School, Boston, MA, USA; Senior Attending Physician, Dana-Farber Cancer Institute, Boston, MA, USA
- Wendy Chen, MD, MPH, Instructor, Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA, USA
- Andrew Wardley, MBChB, MRCP, MSc, MD, CCST, FRCP, Consultant Medical Oncologist & Clinical Research Lead for the Manchester Breast Centre, Christie Hospital NHS Trust, Manchester, UK
Written by highly eminent authors, Breast Cancer - a title in the Dana-Farber Cancer Institute series - is produced in full color and is richly illustrated throughout, providing a review of each cancer including its incidence, epidemiology, etiology and histopathology, together with the clinical features. Diagnostic studies and current clinical and pathological staging are also given. Detailed tables are provided with histopathological classification, diagnostic studies and, when important, prognostic factors. Current therapies are also discussed in detail, together with useful algorithms to aid treatment decisions. Practical issues relating to management are also given such as dealing with systemic and mucocutaneous reactions to chemotherapy, including alopecia, fatigue and extravasation.
The book is aimed at trainee oncologists and general physicians who manage cancer patients outside of specialist centers.
Paperback, 176 Pages
The role of molecular probes and other markers in the diagnosis and characterization of malignancy
Breast cancer: incidence, screening, histology and staging
Treatment of breast cancer
Systemic and mucocutaneous reactions to chemotherapy